DEA schedule
Is amphetamine a controlled substance?
Federal schedule for amphetamine from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Amphetamine is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Amphetamine (Schedule II).
Run it in Rivvi
Which 2027 plans near you dropped or restricted amphetamine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 58 prescription listings from 16 labelers, all Schedule II |
| DEA controlled substances list | Amphetamine: Schedule II |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Amphetamine | 1100 | II | No | Dexedrine; Adderall; Obetrol | Listed by name |
Amphetamine NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 70165-020 | Adzenys XR-ODT | tablet, orally disintegrating | 12.5 mg/1 | Neos Therapeutics Brands, LLC | CII |
| 70165-025 | Adzenys XR-ODT | tablet, orally disintegrating | 15.7 mg/1 | Neos Therapeutics Brands, LLC | CII |
| 70165-030 | Adzenys XR-ODT | tablet, orally disintegrating | 18.8 mg/1 | Neos Therapeutics Brands, LLC | CII |
| 70165-005 | Adzenys XR-ODT | tablet, orally disintegrating | 3.1 mg/1 | Neos Therapeutics Brands, LLC | CII |
| 70165-010 | Adzenys XR-ODT | tablet, orally disintegrating | 6.3 mg/1 | Neos Therapeutics Brands, LLC | CII |
| 70165-015 | Adzenys XR-ODT | tablet, orally disintegrating | 9.4 mg/1 | Neos Therapeutics Brands, LLC | CII |
| 24478-102 | Dyanavel XR | suspension, extended release | 2.5 mg/mL | NextWave Pharmaceuticals, Inc | CII |
| 24478-108 | DYANAVEL XR | tablet, extended release | 10 mg/1 | NextWave Pharmaceuticals, Inc | CII |
| 24478-109 | DYANAVEL XR | tablet, extended release | 15 mg/1 | NextWave Pharmaceuticals, Inc | CII |
| 24478-110 | DYANAVEL XR | tablet, extended release | 20 mg/1 | NextWave Pharmaceuticals, Inc | CII |
| 24478-106 | DYANAVEL XR | tablet, extended release | 5 mg/1 | NextWave Pharmaceuticals, Inc | CII |
| 0480-3318 | Amphetamine | tablet, orally disintegrating | 12.5 mg/1 | Teva Pharmaceuticals, Inc. | CII |
| 0480-3319 | Amphetamine | tablet, orally disintegrating | 15.7 mg/1 | Teva Pharmaceuticals, Inc. | CII |
| 0480-3320 | Amphetamine | tablet, orally disintegrating | 18.8 mg/1 | Teva Pharmaceuticals, Inc. | CII |
| 0480-3315 | Amphetamine | tablet, orally disintegrating | 3.1 mg/1 | Teva Pharmaceuticals, Inc. | CII |
| 0480-3316 | Amphetamine | tablet, orally disintegrating | 6.3 mg/1 | Teva Pharmaceuticals, Inc. | CII |
| 0480-3317 | Amphetamine | tablet, orally disintegrating | 9.4 mg/1 | Teva Pharmaceuticals, Inc. | CII |
| 62542-020 | Amphetamine Extended-Release | tablet, orally disintegrating | 12.5 mg/1 | Neos Therapeutics, LP | CII |
| 62542-025 | Amphetamine Extended-Release | tablet, orally disintegrating | 15.7 mg/1 | Neos Therapeutics, LP | CII |
| 62542-030 | Amphetamine Extended-Release | tablet, orally disintegrating | 18.8 mg/1 | Neos Therapeutics, LP | CII |
| 62542-005 | Amphetamine Extended-Release | tablet, orally disintegrating | 3.1 mg/1 | Neos Therapeutics, LP | CII |
| 62542-010 | Amphetamine Extended-Release | tablet, orally disintegrating | 6.3 mg/1 | Neos Therapeutics, LP | CII |
| 62542-015 | Amphetamine Extended-Release | tablet, orally disintegrating | 9.4 mg/1 | Neos Therapeutics, LP | CII |
| 0406-1220 | Amphetamine Sulfate | tablet | 10 mg/1 | SpecGx LLC | CII |
| 0527-2525 | AMPHETAMINE SULFATE | tablet | 10 mg/1 | Lannett Company, Inc. | CII |
| 13107-260 | Amphetamine Sulfate | tablet | 10 mg/1 | Aurolife Pharma, LLC | CII |
| 42806-030 | Amphetamine Sulfate | tablet | 10 mg/1 | Epic Pharma LLC | CII |
| 43547-458 | AMPHETAMINE SULFATE | tablet | 10 mg/1 | Solco Healthcare US, LLC | CII |
| 43598-898 | Amphetamine sulfate | tablet | 10 mg/1 | DR. REDDY'S LABORATORIES INC | CII |
| 52536-059 | Amphetamine Sulfate | tablet | 10 mg/1 | Wilshire Pharmaceuticals, Inc. | CII |
| 63629-1114 | AMPHETAMINE SULFATE | tablet | 10 mg/1 | Bryant Ranch Prepack | CII |
| 63629-2078 | AMPHETAMINE SULFATE | tablet | 10 mg/1 | Bryant Ranch Prepack | CII |
| 63629-2498 | Amphetamine Sulfate | tablet | 10 mg/1 | Bryant Ranch Prepack | CII |
| 69238-1564 | Amphetamine Sulfate | tablet | 10 mg/1 | Amneal Pharmaceuticals NY LLC | CII |
| 69292-107 | Amphetamine Sulfate | tablet | 10 mg/1 | Amici Pharma, Inc. | CII |
| 70010-041 | Amphetamine Sulfate | tablet | 10 mg/1 | Granules Pharmaceuticals Inc. | CII |
| 71335-2990 | AMPHETAMINE SULFATE | tablet | 10 mg/1 | Bryant Ranch Prepack | CII |
| 72162-1088 | AMPHETAMINE SULFATE | tablet | 10 mg/1 | Bryant Ranch Prepack | CII |
| 72162-1369 | AMPHETAMINE SULFATE | tablet | 10 mg/1 | Bryant Ranch Prepack | CII |
| 72162-1613 | Amphetamine Sulfate | tablet | 10 mg/1 | Bryant Ranch Prepack | CII |
Showing 40 of 58 listings.
Questions
Is amphetamine a controlled substance?
Yes. Amphetamine is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Amphetamine (Schedule II).
Is amphetamine a narcotic?
No. The DEA list does not mark amphetamine as a narcotic (NARC = N) and places it in Schedule II. Its FDA established pharmacologic class is Central Nervous System Stimulant.
What schedule is amphetamine?
Amphetamine is Schedule II in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Amphetamine
- What is Amphetamine used for?FDA label uses
- Generic for Adzenys XR-ODTFDA Orange Book
- What is Adzenys XR-ODT used for?FDA label uses
- Is Adzenys XR-ODT a controlled substance?Schedule II
- What is Dyanavel XR used for?FDA label uses
- Is Dyanavel XR a controlled substance?Schedule II
- Generic for Dyanavel XRFDA Orange Book
- What is Evekeo used for?FDA label uses
- Is Evekeo a controlled substance?Schedule II
- Central Nervous System Stimulants listFDA drug class
- NDC 24478-102Amphetamine NDC record
- NDC 24478-106Amphetamine NDC record
- NDC 24478-108Amphetamine NDC record
- Schedule II drugs listDEA schedule